Hybrid Delivery to Increase Access and Sustainability: Evaluating ezParent Implementation
Klein Buendel, Inc. · with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Ohio State University · NCT07417930
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 516
- US sites recruiting
- 1
- Study start
- July 27, 2026
- Record last updated
- August 3, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this study is to evaluate the effects of the hybrid ezParent program (e.g., web-based training program plus synchronous group sessions) on parent and child outcomes in a community setting serving parents of children 2-5 years old. Parent participants will complete surveys at baseline, and 10 and 24-weeks post baseline.
Being studied: ezParent
Conditions: Parenting; Prevention; Program Implementation; Early Childhood
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Parent or legal guardian of a 2-5-year-old child receiving services at the partnering organization site.
- Speaks English or Spanish.
- Has a smartphone, tablet, or computer with Wi-Fi access to receive the ezParent program.
Exclusion Criteria
- Parents who have previously participated in CPP or ezParent will be excluded.
Recruiting US locations
The Ohio State University
Columbus, OH 43210
Site contact: Susan M Breitenstein, PhD · 614-688-4614 · breitenstein.5@osu.edu
Study contacts (from the official record)
- Susan M Breitenstein, PhD · 614-688-4614 · breitenstein.5@osu.edu
Similar studies in Ohio
All healthy volunteers studies in Ohio →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
Hanmi Pharmaceutical Company Limited
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
LH-001 vs Placebo in Healthy Participants
Chien-Liang Lin
- Location
- Columbus, OH
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Beachwood, OH + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
A Study of V132 in Healthy Older Participants (V132-001)
Merck Sharp & Dohme LLC
- Location
- Columbus, OH + 9 other US sites
- Eligibility basics
- Ages 50–75